MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways

Siegel, 2013, Cancer statistics, 2013, CA Cancer J Clin, 63, 11, 10.3322/caac.21166

Lan, 2012, Analysis of the seventh edition of American Joint Committee on colon cancer staging, Int J Colorectal Dis, 27, 657, 10.1007/s00384-011-1366-6

Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002

Pasquinelli, 2012, MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship, Nat Rev Genet, 13, 271, 10.1038/nrg3162

Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5

Asangani, 2008, MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer, Oncogene, 27, 2128, 10.1038/sj.onc.1210856

Ozen, 2008, Widespread deregulation of microRNA expression in human prostate cancer, Oncogene, 27, 1788, 10.1038/sj.onc.1210809

Calin, 2006, MicroRNA signatures in human cancers, Nat Rev Cancer, 6, 857, 10.1038/nrc1997

Wang, 2008, Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth, PLoS One, 3, e2557, 10.1371/journal.pone.0002557

Babashah, 2011, The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis, Eur J Cancer, 47, 1127, 10.1016/j.ejca.2011.02.008

Li, 2011, Down-regulation of miR-126 expression in colorectal cancer and its clinical significance, Med Oncol, 28, 1054, 10.1007/s12032-010-9637-6

Tavazoie, 2008, Endogenous human microRNAs that suppress breast cancer metastasis, Nature, 451, 147, 10.1038/nature06487

Feng, 2010, miR-126 functions as a tumour suppressor in human gastric cancer, Cancer Lett, 298, 50, 10.1016/j.canlet.2010.06.004

Guo, 2008, The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers, Genes Chromosomes Cancer, 47, 939, 10.1002/gcc.20596

Liu, 2009, MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo, Lung Cancer, 66, 169, 10.1016/j.lungcan.2009.01.010

Zhang, 2008, The cell growth suppressor, mir-126, targets IRS-1, Biochem Biophys Res Commun, 377, 136, 10.1016/j.bbrc.2008.09.089

Hamada, 2012, MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9, Mol Cancer Res, 10, 3, 10.1158/1541-7786.MCR-11-0272

Zhang, 2013, miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis, Nat Cell Biol, 15, 284, 10.1038/ncb2690

Zhang, 2013, Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer, Oncol Rep, 30, 1976, 10.3892/or.2013.2633

Miko, 2011, miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5, FEBS Lett, 585, 1191, 10.1016/j.febslet.2011.03.039

Li, 2013, MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway, Mol Cell Biochem, 380, 107, 10.1007/s11010-013-1664-0

Li, 2008, Distinct microRNA expression profiles in acute myeloid leukemia with common translocations, Proc Natl Acad Sci USA, 105, 15535, 10.1073/pnas.0808266105

Fish, 2008, miR-126 regulates angiogenic signaling and vascular integrity, Dev Cell, 15, 272, 10.1016/j.devcel.2008.07.008

Wang, 2008, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis, Dev Cell, 15, 261, 10.1016/j.devcel.2008.07.002

Otsubo, 2011, MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis, PLoS One, 6, e16617, 10.1371/journal.pone.0016617

Oberlin, 1996, The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1, Nature, 382, 833, 10.1038/382833a0

Kim, 2005, Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival, J Clin Oncol, 23, 2744, 10.1200/JCO.2005.07.078

Murakami, 2013, The role of CXCR3 and CXCR4 in colorectal cancer metastasis, Int J Cancer, 132, 276, 10.1002/ijc.27670

Punj, 2010, Kaposi’s sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a, Oncogene, 29, 1835, 10.1038/onc.2009.460

Tano, 2011, microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4, PLoS One, 6, e23114, 10.1371/journal.pone.0023114

Labbaye, 2008, A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis, Nat Cell Biol, 10, 788, 10.1038/ncb1741

Yasumoto, 2006, Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer, Cancer Res, 66, 2181, 10.1158/0008-5472.CAN-05-3393

Wendt, 2008, Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells, Gastroenterology, 135, 508, 10.1053/j.gastro.2008.05.033

Shen, 2010, Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways, Pancreas, 39, 81, 10.1097/MPA.0b013e3181bb2ab7

Brand, 2005, CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation, Exp Cell Res, 310, 117, 10.1016/j.yexcr.2005.07.006